Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection

Vaccine

Volumn 34, Issue 6, 2016, Pages 869-873

  Li, Xi ^a   Wiesen, Eric ^b   Diorditsa, Sergey ^b   Toda, Kohei ^b   Duong, Thi Hong ^c   Nguyen, Lien Huong ^c   Nguyen, Van Cuong ^c   Nguyen, Tran Hien ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

Author keywords

Adverse events following immunization; Disease burden; Hepatitis B; Vaccination coverage; Viet Nam

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ARTICLE; CHRONIC HEPATITIS B; DRUG EFFICACY; HUMAN; INFECTION CONTROL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION; VIET NAM; ADULT; ADVERSE EFFECTS; CHILD; FEMALE; HEPATITIS B, CHRONIC; MALE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL;

ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; MALE; MODELS, THEORETICAL; VACCINATION; VIETNAM;

EID: 84958769425     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.05.067     Document Type: Article

References (22)

1. Lan P., Lundborg C.S., Phuc H., Sihavong A., Unemo M., Chuc N., et al. Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect 2008, 84(2):126-132.
2. Duong T.H., Nguyen P.H., Henley K., Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev 2009, 10(1):97.
3. Nguyen V.T.T., McLaws M.L., Dore G.J. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol 2007, 22(12):2093-2100.
4. Do S.H., Yamada H., Fujimoto M., Ohisa M., Matsuo J., Akita T., et al. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam. Hepatol Res 2014.
5. World Health Organization Hpeatitis B fact sheet 2015, World Health Organization, 〈http://www.who.int/mediacentre/factsheets/fs204/en/〉 (accessed on February 24). (Updated July 2014).
6. WHO/IARC GLOBOCAN 2012, liver cancer: estimated incidence, all ages, both sexes 2015, WHO/IARC, Available from 〈http://globocan.iarc.fr/old/summary_table_site-html.asp?selection=14070&title=Liver&sex=1&type=0&window=1&africa=1&america=2&asia=3&europe=4&oceania=5&build=6&sort=4&submit=%C2%A0Execute〉 (accessed on February 24, 2015).
7. WHO/IARC GLOBOCAN 2012, Viet Nam: estimated cancer incidence, all ages, both sexes 2015, WHO/IARC, Available from 〈http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=213704&title=Viet+Nam&sex=0&type=0&window=1&sort=2&submit=%C2%A0Execute〉 (accessed on February 24, 2015).
8. Milne A., West D.J., Chinh D.V., Moyes C.D., Poerschke G. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol 2002, 67(3):327-333.
9. Assateerawatt A., Tanphaichitr V.S., Suvatte V., In-ngarm L. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates. Asian Pac J Allergy Immunol 2011, 9(2):89.
10. FitzSimons D., François G., Hall A., McMahon B., Meheus A., Zanetti A., et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005, 23(32):4158-4166.
11. Nguyen T.H., Vu M.H., Nguyen V.C., Nguyen L.H., Toda K., Nguyen T.N., et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine 2014, 32(2):217-222.
12. World Health Organization Adverse Events Following Immunization (AEFI) 2015, World Health Organization, 〈http://www.who.int/vaccine_safety/initiative/detection/AEFI/en/〉 (accessed on February 24).
13. World Health Organization Safety of Quinvaxem (DTwP-HepB-Hib) pentavalent vaccine 2015, World Health Organization, 〈http://www.who.int/immunization_standards/vaccine_quality/quinvaxem_pqnote_may2013/en/〉 (accessed on February 24). Updated May 10, 2013.
14. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34(6):1329-1339.
15. Le Viet N.T.N.L., Ty P.X., Björkvoll B., Hoel H., Gutteberg T., Husebekk A., et al. Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam. Indian J Med Res 2012, 136(1):74.
16. Hipgrave D.B., Van N.T., Huong V.M., Long H.T., Do Trung D., Tuan T.N., et al. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg 2003, 69(3):288-294.
17. Nakata S., Song P., Duc D.D., Quang N.X., Murata K., Tsuda F., et al. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol 1994, 9(4):416-419.
18. Goto A., Nguyen Q.V., Pham N.M., Kato K., Cao T.P.N., Le T.H.C., et al. Prevalence of and factors associated with reproductive tract infections among pregnant women in ten communes in Nghe An Province, Vietnam. J Epidemiol 2005, 15(5):163-172.
19. WHO/UNICEF WHO/UNICEF joint reporting form of Viet Nam 2013, WHO/UNICEF, (unpublished).
20. United Nations Population Division World population prospects, the 2012 revision 2015,
21. World Health Organization WHO and UNICEF estimates of immunization coverage: Viet Nam 2014, World Health Organization, 〈http://www.data.unicef.org/fckimages/uploads/1421187961_viet_nam_rev_13_FINAL.pdf〉 (accessed on February 24, 2015).
22. Rao C., Osterberger B., Anh T.D., MacDonald M., Chúc N.T.K., Hill P.S. Compiling mortality statistics from civil registration systems in Viet Nam: the long road ahead. Bull World Health Organ 2010, 88(1):58-65.